Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial-Reference-Cited by-同舟云学术

Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial

Published:2020-06 Issue:6 Volume:7 Page:e469-e478
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Maggio Aurelio,Kattamis Antonis,Felisi Mariagrazia,Reggiardo Giorgio,El-Beshlawy Amal,Bejaoui Mohamed,Sherief Laila,Christou Soteroula,Cosmi Carlo,Della Pasqua Oscar,Del Vecchio Giovanni Carlo,Filosa Aldo,Cuccia Liana,Hassab Hoda,Kreka Manika,Origa Raffaella,Putti Maria Caterina,Spino Michael,Telfer Paul,Tempesta Bianca,Vitrano Angela,Tsang Yu Chung,Zaka Ariana,Tricta Fernando,Bonifazi Donato,Ceci Adriana

Publisher

Elsevier BV

Subject

Hematology

Reference19 articles.

1. Hemoglobinopathies worldwide: present and future;Weatherall;Curr Mol Med,2008

2. Guidelines for the management of transfusion dependent thalassaemia (TDT);Cappellini,2014

3. Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: data from LICNET;Vitrano;Eur J Haematol,2018

4. The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major;Di Maggio;Br J Haematol,2017

5. An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload;Ceci;Expert Opin Orphan Drugs,2019

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR technology in human diseases;MedComm;2024-07-29

2. Molecular and therapeutic landscape of ferroptosis in skin diseases;Chinese Medical Journal;2024-07-08

3. JWA binding to NCOA4 alleviates degeneration in dopaminergic neurons through suppression of ferritinophagy in Parkinson's disease;Redox Biology;2024-07

4. Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years;Blood Cells, Molecules, and Diseases;2024-07

5. Impacts of oxidative stress and anti-oxidants on the development, pathogenesis, and therapy of sickle cell disease: A comprehensive review;Biomedicine & Pharmacotherapy;2024-07